IE
PYXS icon

Israel Englander’s Pyxis Oncology PYXS Stock Holding History

Israel Englander’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-16,900
Closed -$62K – 6368
2024
Q3 		$62K Buy
+16,900
New +$59.1K ﹤0.01% 5661
2024
Q2 		– Sell
-32,000
Closed -$136K – 6405
2024
Q1 		$136K Buy
+32,000
New +$135K ﹤0.01% 5498

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Israel Englander's PYXS Position: Q2 2026 in Review

Israel Englander reduced its Pyxis Oncology (PYXS) stake by 41% in Q2 2026, selling an estimated $315K and leaving 233,004 shares worth $701K. The position accounts for ﹤0.01% of the portfolio, ranked #4552.

Israel Englander first reported a position in PYXS in Q4 2021 and has held it in 16 quarters since. The position peaked at $7M in Q3 2024. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • Israel Englander held 233,004 shares of Pyxis Oncology worth $701K as of Q2 2026.
  • Israel Englander sold 164,621 Pyxis Oncology shares in Q2 2026, an estimated $315K.
  • Pyxis Oncology made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4552 holding.
  • Israel Englander first reported a position in Pyxis Oncology in Q4 2021 and has held it in 16 quarters since.
  • Israel Englander's Pyxis Oncology position peaked at $7M in Q3 2024.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.